<DOC>
	<DOCNO>NCT00300963</DOCNO>
	<brief_summary>The purpose study test safety effectiveness talnetant vs. risperidone vs. placebo reduce positive negative symptom acutely psychotic schizophrenia patient .</brief_summary>
	<brief_title>Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Inclusion criterion : Subjects must schizophrenia secondary another medical condition substance abuse . Require inpatient hospitalization . Women may enroll childbearing potential OR protocolapproved birth control method . Exclusion criterion : Subject first episode schizophrenia . Subject psychotic disorder bipolar disorder . Subject schizophrenia symptom take another medicine drug abuse , due general medical condition . Subject recent history substance dependence , test positive illicit drug . Subject unstable medical disorder , significant medical disorder include autistic disorder , organic brain disease , liver dysfunction , epilepsy seizure , increase risk develop cerebrovascular problem like stroke . Subject significant abnormality screen test ( ECGs , lab , physical examination , etc. ) . Subject pose current serious suicidal homicidal risk . Subject positive pregnancy test , lactate plan become pregnant within one month study . Subject recently currently participate another clinical study . Subject stabilize current schizophrenia treatment . Subject need take medicine permit study , recently ECT ( electroconvulsive therapy ) TMS ( transcranial magnetic stimulation ) . Subject nonresponsive two adequate trial antipsychotic treatment past 2 year . Subject allergic significant reaction study drug , ca n't take risperidone .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>psychosis</keyword>
	<keyword>cognition</keyword>
</DOC>